Popular Science magazine names UCLA professor among ‘Brilliant 10’

Popular Science magazine has named Aydogan Ozcan, an associate professor of electrical engineering and bioengineering at UCLA, one of the world's "Brilliant 10" scientists in its October 2012 issue.

The magazine, which calls its annual list "a celebration of young researchers whose innovations will change the world," recognized Ozcan for his groundbreaking imaging technology that turns everyday smart phones into powerful microscopes for use in medical diagnostics.

These compact, lightweight diagnostic tools have the potential to bring better health care and disease monitoring to impoverished and underserved areas of the globe.

"In many parts of the world, ailments are never even diagnosed," the magazine noted. "Ozcan's medical devices could fix that."

Ozcan has also developed a Google Maps interface to geographically plot test results obtained by his cell-phone microscopes, an advance that could be used to track the spread of various infectious diseases throughout the globe, the magazine said.

Ozcan's research group at the UCLA Henry Samueli School of Engineering and Applied Science has developed a number of lens-less computational imaging technologies for use in a variety of applications, particularly in the field of telemedicine

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Alzheimer's guidelines focus on risk, not diagnosis, in healthy adults